APA (7th ed.) Citation

Hutchison, R. M., Evans, K. C., Fox, T., Yang, M., Barakos, J., Bedell, B. J., . . . Lang, A. E. (2021). Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson’s disease trial. BMC neurology, 21(1), 1-10. https://doi.org/10.1186/s12883-021-02470-8

Chicago Style (17th ed.) Citation

Hutchison, R. Matthew, et al. "Evaluating Dopamine Transporter Imaging as an Enrichment Biomarker in a Phase 2 Parkinson’s Disease Trial." BMC Neurology 21, no. 1 (2021): 1-10. https://doi.org/10.1186/s12883-021-02470-8.

MLA (9th ed.) Citation

Hutchison, R. Matthew, et al. "Evaluating Dopamine Transporter Imaging as an Enrichment Biomarker in a Phase 2 Parkinson’s Disease Trial." BMC Neurology, vol. 21, no. 1, 2021, pp. 1-10, https://doi.org/10.1186/s12883-021-02470-8.